183 related articles for article (PubMed ID: 18019358)
1. Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy.
Gastens MH; Goltry K; Prohaska W; Tschöpe D; Stratmann B; Lammers D; Kirana S; Götting C; Kleesiek K
Cell Transplant; 2007; 16(7):685-96. PubMed ID: 18019358
[TBL] [Abstract][Full Text] [Related]
2. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells.
Koller MR; Manchel I; Newsom BS; Palsson MA; Palsson BO
J Hematother; 1995 Jun; 4(3):159-69. PubMed ID: 7551915
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
4. [Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow].
He Y; Meng HX; Zhang YG; Hou SF; Wang H; Huang Y; Li Q; Han JL; Qiu LG; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1398-402. PubMed ID: 19099652
[TBL] [Abstract][Full Text] [Related]
5. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
[TBL] [Abstract][Full Text] [Related]
6. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
[TBL] [Abstract][Full Text] [Related]
7. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
Varas F; Bernard A; Bueren JA
Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
9. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
[TBL] [Abstract][Full Text] [Related]
10. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system.
Rojewski MT; Fekete N; Baila S; Nguyen K; Fürst D; Antwiler D; Dausend J; Kreja L; Ignatius A; Sensebé L; Schrezenmeier H
Cell Transplant; 2013; 22(11):1981-2000. PubMed ID: 23107560
[TBL] [Abstract][Full Text] [Related]
11. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.
Grisendi G; Annerén C; Cafarelli L; Sternieri R; Veronesi E; Cervo GL; Luminari S; Maur M; Frassoldati A; Palazzi G; Otsuru S; Bambi F; Paolucci P; Pierfranco C; Horwitz E; Dominici M
Cytotherapy; 2010 Jul; 12(4):466-77. PubMed ID: 20353309
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
13. Reinjection of ex vivo-expanded primate bone marrow mononuclear cells strongly reduces radiation-induced aplasia.
Bertho JM; Frick J; Demarquay C; Lauby A; Mathieu E; Dudoignon N; Jacquet N; Trompier F; Chapel A; Joubert C; Lopez M; Aigueperse J; Gorin NC; Gourmelon P; Thierry D
J Hematother Stem Cell Res; 2002 Jun; 11(3):549-64. PubMed ID: 12183840
[TBL] [Abstract][Full Text] [Related]
14. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
15. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
[TBL] [Abstract][Full Text] [Related]
17. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
[TBL] [Abstract][Full Text] [Related]
18. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
Russell AL; Lefavor RC; Zubair AC
Transfusion; 2018 Oct; 58(10):2374-2382. PubMed ID: 30203447
[TBL] [Abstract][Full Text] [Related]
19. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results.
Savelli S; Trombi L; D'Alessandro D; Moscato S; Pacini S; Giannotti S; Lapi S; Scatena F; Petrini M
Cytotherapy; 2018 Apr; 20(4):556-563. PubMed ID: 29429942
[TBL] [Abstract][Full Text] [Related]
20. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.
Alcayaga-Miranda F; Cuenca J; Luz-Crawford P; Aguila-Díaz C; Fernandez A; Figueroa FE; Khoury M
Stem Cell Res Ther; 2015 Mar; 6(1):32. PubMed ID: 25889741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
